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Abstract
Objective
To determine the prevalence of apathy and depression in cerebral small vessel disease
(SVD), and the relationships between both apathy and depression with cognition. To exam-
ine whether apathy is specifically related to impairment in executive functioning and pro-
cessing speed.
Methods
196 patients with a clinical lacunar stroke and an anatomically corresponding lacunar infarct
on MRI were compared to 300 stroke-free controls. Apathy and depression were measured
using the Geriatric Depression Scale, and cognitive functioning was assessed using an
SVD cognitive screening tool, the Brief Memory and Executive Test, which measures exec-
utive functioning/processing speed and memory/orientation. Path analysis and binary logis-
tic regression were used to assess the relation between apathy, depression and cognitive
impairment.
Results
31 participants with SVD (15.8%) met criteria for apathy only, 23 (11.8%) for both apathy
and depression, and 2 (1.0%) for depression only. In the SVD group the presence of apathy
was related to global cognition, and specifically to impaired executive functioning/process-
ing speed, but not memory/orientation. The presence of depression was not related to global
cognition, impaired executive functioning/processing speed or memory/orientation.
Conclusions
Apathy is a common feature of SVD and is associated with impaired executive functioning/
processing speed suggesting the two may share biological mechanisms. Screening for
PLOS ONE | https://doi.org/10.1371/journal.pone.0176943 May 11, 2017 1 / 12
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPENACCESS
Citation: Lohner V, Brookes RL, Hollocks MJ,
Morris RG, Markus HS (2017) Apathy, but not
depression, is associated with executive
dysfunction in cerebral small vessel disease. PLoS
ONE 12(5): e0176943. https://doi.org/10.1371/
journal.pone.0176943
Editor: Josef Priller, Charite Universitatsmedizin
Berlin, GERMANY
Received: October 19, 2016
Accepted: April 19, 2017
Published: May 11, 2017
Copyright: © 2017 Lohner et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information
files.
Funding: This work was supported by a Priority
Program Grant from the Stroke Association (TSA
PPA 2015-02; www.stroke.org.uk). The BMET
Study was supported by a grant from the Stroke
Association (TSA2008/10). Valerie Lohner is
supported by a Stroke Association/British Heart
Foundation Program Grant (TSA BHF 2010/01;
www.bhf.org.uk). Rebecca Brookes is supported
apathy should be considered in SVD, and further work is required to develop and evaluate
effective apathy treatment or management in SVD.
Introduction
Cerebral Small Vessel Disease (SVD) is the most common cause of vascular cognitive impairment
and vascular dementia, with up to 50% of patients with lacunar stroke having some degree of cog-
nitive impairment [1, 2]. These impairments characteristically involve cognitive flexibility, atten-
tion, and processing speed [3–5], with episodic memory relatively spared [6, 7]. Neuropsychiatric
comorbidities, particularly depressive symptoms [8–10] are increasingly being linked to SVD.
Some of the scales used to measure depression include items relating to both apathy and depres-
sion. Recently apathy, rather than depression, has been suggested as the major neuropsychiatric
symptom in this group [11] and in patients with dementia with co-existing WMH [12]. For exam-
ple, in one recent study in patients with clinical lacunar stroke and confluent WMH, apathy, but
not depression, was associated with the extent of white matter damage, estimated using diffusion
tensor imaging (DTI) [11]. Following from this paper, it is important to replicate the finding that
apathy is an important neuropsychiatric symptom in further SVD cohorts, and to determine
whether this association is seen across patients with a wide variety of SVD severity; in this paper
all cases had lacunar infarcts as well as confluent white matter hyperintensities, indicating more
severe disease.
Apathy is a syndrome consisting of behavioral, affective, and cognitive features [13]. It is
commonly considered to be an intrinsic component of cognitive decline [14] with diminished
motivation, initiative and interest, and blunting of emotions as core features [15]. Similarly,
apathy is often considered to be a component of the ‘dysexecutive syndrome’, which can occur
as a result of acquired brain injury or dysfunction involving the fronto-subcortical circuits [16,
17]. This is supported by studies of both Alzheimer’s and Parkinson’s disease [18, 19]. To the
best of our knowledge, studies on the relationship between apathy and impaired cognition in
SVD are currently lacking and hence this needs to be addressed.
In this study we determined firstly the prevalence of both apathy and depression in a popu-
lation with symptomatic lacunar stroke in comparison to a healthy control group. Secondly, in
the SVD group we investigated the relationship between both apathy and depression with cog-
nition, and determined whether apathy is specifically related to executive functioning and pro-
cessing speed.
Materials and methods
Standard protocol approvals, registrations, and patient consents
All participants signed an informed consent form before taking part in this study. The London
Bridge Research Ethics Committee approved this study (11/LO/0636).
Study population
Two-hundred participants with SVD (age range 35 to 100 years) were recruited from stroke
wards and outpatients clinics at 19 sites across the English Stroke Research Network, between
July 2011 and September 2013, as part of a multicenter study to validate a tailored SVD cogni-
tive screening tool (see below for a list of all sites). The sample size was calculated based on a
meta-analysis examining studies investigating the relationship between WMH and cognition;
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PLOS ONE | https://doi.org/10.1371/journal.pone.0176943 May 11, 2017 2 / 12
by a BHF Project Grant (PG/13/30/30005).
Recruitment to the BMET Study was supported by
the English National Institute of Health Research
(NIHR) Clinical Stroke Research Network (www.
crn.nihr.ac.uk/stroke). Hugh Markus is supported
by an NIHR Senior Investigator award (www.nihr.
ac.uk) and his work is supported by the Cambridge
University Hospital Comprehensive NIHR
Biomedical Research Unit (www.cambridge-brc.
org.uk). The funders had no role in study design,
data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing interests: The authors have declared
that no competing interests exist.
taking into account that the sample of 200 participants should lead to acceptable significance
levels for a range of different analyses, including additional correction for multiple compari-
sons [20]. SVD was defined as having a symptomatic lacunar syndrome [21] with MRI confir-
mation of an anatomically relevant infarct on MRI. For MRI in the acute phase this was an
acute infarct on diffusion-weighted imaging, and for non-acute MRIs an anatomically relevant
lacunar infarct visible on FLAIR or T1 sequences. Exclusion criteria included any stroke sub-
type than SVD; this included stenosis >50% in the extracranial or intracranial cerebral vessels,
or previous carotid endarterectomy, cardioembolic source of stroke, defined according to the
TOAST criteria [22] as high or moderate probability, and/or the presence of a cortical infarct
>1cm diameter on MRI. Further exclusion criteria were clinical dementia, and lack of suffi-
cient fluency in English to allow cognitive testing. All participants were tested at least three
months post-stroke to reduce any acute effects of stroke on cognitive performance. Participant
MRI scans were centrally reviewed to confirm eligibility.
Patients with lacunar stroke with or without WMH were included. However, the degree of
WMH was assessed on central blinded review using the semi-quantitative Fazekas’ scale [23].
The SVD cohort was then categorized into those with either lacunar infarcts without WMH
(Fazekas scale 0 or 1; n = 122), or lacunar infarcts with confluent WMH (Fazekas2; n = 74).
Three-hundred healthy controls were recruited from local family doctors practices or other
volunteer groups in South London. They were matched on socioeconomic status and years of
education, and were included as a reference group for cognitive, apathy and depression scores.
Individuals with cardiovascular risk factors and other comorbidities were included, but indi-
viduals with a past history of stroke, transient ischemic attacks, and other major central neuro-
logical or major psychiatric diseases were excluded [20]. Brain imaging was not performed in
the controls.
For both groups hypertension, hypercholesterolemia and diabetes mellitus were recorded.
Hypertension was defined as being on anti-hypertensive drugs or having blood pressure
greater than 140mmHg systolic or 90mmHg diastolic. Hypercholesterolemia was defined as
being on cholesterol lowering therapy or a serum cholesterol > 5.2mmol/l. Diabetes mellitus
was defined as a clinical diagnosis of the disease.
Neuropsychological assessment
Cognition was assessed using the Brief Memory and Executive Test (BMET: www.bmet.info)
[20, 24], which has been previously used in studies with SVD [11, 25–27]. The BMET consists
of eight tasks divided into two main categories for sub-scaling, namely: 1. executive functioning/
processing speed which includes letter-number matching, motor-sequencing, letter-sequencing,
and number-letter sequencing; and 2. memory/orientation which includes five-item repetition,
recall, and recognition memory, and basic time and place orientation questions. A full descrip-
tion of the tasks can be found in previously reported studies [20, 24].
The BMET has an aggregate overall measure, termed the cognitive index score, with a previ-
ously defined clinical cut-off score of 13 [20]. For the executive functioning/processing speed
and memory/orientation subscales, the scores are considered parametrically. Performance
across all test measures was made comparable by converting the raw-scores into z-scores based
on the control mean and standard deviations stratified by age band. Compound scores for the
two main subdomains were then calculated by averaging the relevant z-scores. The test scores
of all sequencing task measures were inverted such that higher z-scores indicate better perfor-
mance. Glass’ delta was used to compute effect sizes, and defined cognitive impairment as a
score below a cut-off of 1.5 standard deviations (SDs) below the standardized mean of the con-
trol data [28].
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Premorbid IQ was assessed by use of the revised National Adult Reading Test (NART-R)
applying the UK re-standardization by Nelson and Willison [29].
Apathy and depression
All participants completed the Geriatric Depression Scale (GDS), a thirty item self-report
screening scale for depression [30]. Past research has shown that the GDS has good internal
consistency (α = .86) [30], and a sensitivity of approximately 80% when compared to clinical
diagnoses of depression [31]. Participants were asked to answer yes/no to questions regarding
depressive symptoms. The apathy and depression questions from the scale were separated
based on a model that has been previously used, deriving separate scales [11]. The apathy scale
had a range of 0–6 and consisted of the following six items: ‘prefer to stay home’, ‘avoid social
gatherings’, ‘dropped activities and interests’, ‘find life very exciting’, ‘hard to start new proj-
ects’ and ‘full of energy’. The depression scale, which included the remaining 24 items, had a
range of 0–24. Glass’ delta was used to compute effect sizes, and defined apathy and depression
as having a score 1.5 SDs below the mean of the control data. To confirm the validity of the
apathy and depression subscale in this sample, we adopted a confirmatory factor analysis
approach conducted in MPLUS. The structure of the apathy/depression scales was confirmed,
with adequate model fit statistics (χ2(61) = 87.034, comparative fit index (CFI) = .979, root
mean square error of approximation (RMSEA) = .047).
Statistical analyses
Differences between participants with SVD and controls on descriptive variables and clinical
parameters were analyzed using univariate ANOVA and χ2 tests. All analyses were corrected
for age, gender and premorbid IQ.
A model of apathetic and depressive symptoms, and executive function/processing speed
and memory/orientation functions in the SVD patient group was initially evaluated using
structural equation modelling (SEM) path analyses in AMOS v.23 (http://amosdevelopment.
com). The advantage of this technique is that it allows examination of the relationships of apa-
thetic and depressive symptoms to cognition whilst taking their covariance into account. It
also allowed us to model the impact of executive function/processing speed on memory/orien-
tation in this group. The variance in all core variables (apathetic and depressive symptoms,
executive functioning/ processing speed, memory/orientation) accounted for by age and pre-
morbid IQ, was controlled for in the models. Missing data were examined and found to be few
and sporadic (NART: n = 3). Therefore these data were imputed using an expectation maximi-
zation algorithm, as part of SPSS’s Missing Value Analysis Tool.
Model parameters were estimated using maximum likelihood estimation. To evaluate
model fit we applied multiple criteria as recommended by Kline [32]: 1) The CFI where higher
values indicate larger improvement over a null model (>.90 indicates a good fit); 2) The
RMSEA measures the fit of the specified model to the sample covariance matrix. RMSEA <
.05 indicates a good fitting model. PCLOSE gives a probability value for H0 RMSEA.05,
therefore a p-value greater than .05 indicates a good fit; 3) Chi-squared test for lack of fit (non-
significant results indicate a good fit). Chi-squared difference was calculated to look for a sig-
nificant change in fit from model 1 to model 2 and from model 1 to model 3. Bootstrapping
(2000 samples) was also employed to estimate indirect effects in the model.
A binary logistic regression was used to determine whether or not clinically relevant apathy,
depression, or cognitive deficits were co-related. Here, patients with clinically relevant incre-
ments in apathy and depression or impairments on the cognitive indices were defined based
on scores 1.5 SD deviation from the control population values [33]. Then for each index of
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cognition a binary logistic regression was used to examine prediction of impairment based on
apathy and depression. Also accounted for in the model were age, gender and premorbid IQ.
The same analyses were done with additional correction for the degree of WMH. We applied
additional Bonferroni correction to correct for multiple comparisons. These analyses were per-
formed using IBM SPSS Statistics version 23.
Results
Descriptive statistics
Table 1 presents the demographic and clinical characteristics of both groups. Two participants
over 90 years and two participants under 40 years were not included in this analysis due to
lack of normative data for these age decades, leaving 196 SVD cases and 300 controls. The two
groups did not differ significantly in age and years of education. There were more male partici-
pants in the SVD group and the controls had a slightly higher premorbid IQ. Missing data for
key variables were as follows: years of education, SVD = 4; body mass index, SVD = 9, con-
trols = 1; alcohol units per week, SVD = 3.
On Fazekas scale grading, 93 patients (47.4%) with SVD had no WMH, 29 patients (14.8%)
had punctuate WMH, 30 patients (15.3%) had beginning confluence of WMH, and 44 patients
(22.4%) had large confluent areas of WMH.
Prevalence of apathy and depression and cognitive impairment
Thirty-one patients with SVD (15.8%) met the criteria for apathy only, 23 participants (11.8%)
met the criteria for both apathy and depression, and 2 participants (1.0%) met the criteria for
depression only. Apathy was more common in SVD cases than controls (SVD: 27.6% vs. con-
trols: 10.7%, p = .0001) but there was no significant difference in the prevalence of depression
(SVD: 12.8% vs. controls: 9.7%, p = .175).
Table 1. Demographic and clinical variables for participants with SVD and controls.
SVD Controls p-values
(n = 196) (n = 300)
Age 63.51 (9.91) 62.55 (13.78) p = .401
Male Gender 133 (67.9%) 138 (46%) p = .000
Premorbid IQ 114.64 (9.74) 117.34 (7.05) p = .000
Years of education 13.61 (3.80) 14.01 (2.80) p = .184
Fazekas scale WMH 2 74 (37.8%)
Hypertension 145 (74.0%) 83 (27.7%) p = .000
Hyperlipidaemia 154 (78.6%) 72 (24.0%) p = .000
Diabetes 45 (23.0%) 18 (6.0%) p = .000
Smoking (ever) 111 (56.6%) 127 (42.3%) p = .000
Alcohol intake (units/week) 8.70 (14.69) 11.57 (12.94) p = .023
Body mass index (kg/m2) 28.26 (5.37) 25.92 (5.11) p = .000
Apathy 54 (27.6%) 32 (10.7%) p = .000
Depression 25 (12.8%) 29 (9.7%) p = .175
Total Cognitive Index 13.59 (2.86) 15.15 (1.56) p = .000
Memory & Orientation 6.74 (1.56) 7.49 (1.01) p = .000
Executive Functioning & Processing Speed 6.84 (1.85) 7.66 (.93) p = .000
Values presented are mean (SD) or number (%). Statistical tests presented are univariate ANOVA for continuous variables and χ2 tests for categorical
variables. SVD–cerebral Small Vessel Disease; BMET–Brief Memory and Executive Test.
https://doi.org/10.1371/journal.pone.0176943.t001
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The degree of WMH was not related to the magnitude of apathetic symptoms (F(3,196) =
.984, p = .401), the magnitude of depressive symptoms (F(3,196) = .431, p = .731), presence of
apathy (p = .3017) or presence of depression (p = .241).
The SVD group performed worse than the control group on the Total Cognitive Index
score, and the two sub-indices, executive functioning/processing speed and memory/orienta-
tion (Table 1).
Path analysis of the association between apathy, depression and
cognition
The path analysis model is shown in Fig 1. Examination of the individual paths within the model
indicated that apathetic symptoms were related to both the executive functioning/processing speed
(β = -.353, p< .001) and memory/orientation indices (β = -.221, p = .019). Depressive symptoms,
however, were not related to executive functioning/processing speed (β = .149, p = .118), nor mem-
ory/orientation (β = .008, p = .934). Bootstrap analyses showed a significant indirect effect of apathy
on memory/orientation via executive function/processing speed (β = -.080; 95% CI:-.158, -.034,
p< .001) There was a strong covariance between apathetic and depressive symptoms (β = -.718,
p< .001). The model was well supported by fit statistics (χ2(1) = 1.846, p = .174; CFI = .996;
RMSEA = .066, PCLOSE = .274).
Associations with the presence of apathy and depression with cognitive
indices
Binary logistic regression (Table 2) revealed that the presence of apathy (OR: 2.791, p = .014,
CI: 1.323–6.325), but not the presence of depression (OR: .905, p = .858, CI: .301–2.717), was
inversely related to the total cognitive index. When cognition was split into separate indices,
the presence of apathy (OR: 2.371, p = .041, CI: 1.033–5.439) was related to impaired executive
functioning/processing speed, but not to memory/orientation (OR: 1.505, p = .394, CI: .588–
3.853). The presence of depression was not related to impaired executive functioning/ process-
ing speed (OR: 1.249, p = .692, CI: .415–3.762) or to memory/orientation (OR: 1.631, p = .426,
CI: .489–5.446). Additional correction for the degree of WMH did not change these results (S1
Table). After correcting for multiple comparisons by using Bonferroni correction, the
Fig 1. Path analysis model. Path analysis model showing that the magnitude of apathetic symptoms, but not depressive symptoms, is associated with
memory/orientation and executive functioning/ processing speed. Premorbid IQ and age were both regressed into the model (not displayed). There was a
strong covariance between age and depressive symptoms (β = -.30, p < .001), and between premorbid IQ and executive function/processing speed (β =
.35, p < .001) and memory/orientation (β = .16, p = .019). * p < .05; ** p < .005.
https://doi.org/10.1371/journal.pone.0176943.g001
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significance level was at .0167. This did not change the association between presence of apathy
and impaired total cognitive index; the association between the presence of apathy and
impaired executive functioning/processing speed was no longer significant.
Discussion
Our results suggest that apathy, and not depression, may be the predominant neuropsychiatric
symptom associated with SVD. We found that apathy is highly prevalent in SVD, even in
absence of depression, while the prevalence of depression itself was not significantly more
common than in a similarly aged stroke-free control group. Apathy was unrelated to the
degree of WMH in this study, indicating that apathy is present in SVD across patients with
varying degrees of WMH. Furthermore the presence of apathy was associated with the extent
of cognitive impairment, and specifically the impairment in executive dysfunction/processing
speed. This implies that apathy may share underlying mechanisms with executive dysfunction
and impaired processing speed which are the characteristic cognitive impairments seen in
SVD.
We showed a dissociation between apathy and depression in patients with SVD and con-
firmed this by use of a confirmatory factor analysis. These findings are consistent with a previ-
ous study in a different cohort of patients with SVD, who had more severe disease with
confluent WMH in addition to symptomatic lacunar stroke [11]. According to our criteria,
16% of patients with SVD had apathy but not depression, while 12% had both apathy and
depression. Surprisingly only 1% of the patients had depression only. While depression is still
an important neuropsychiatric comorbidity of SVD, the current data suggest that apathy may
be the main underlying non-cognitive psychological disorder. Many depression scales include
both apathetic and depressive symptoms, and it may be the failure to differentiate these that
has led to an over-diagnosis of depression in SVD and an under-diagnosis of apathy.
Our binary logistic regression analysis revealed that the presence of apathy, but not depres-
sion, was associated with impaired cognitive index. After splitting global cognition into separate
indices, we observed an association between the presence of apathy and executive dysfunction/
processing speed, but not with memory/orientation. However, this association between apathy
and impaired executive functioning/processing speed became non-significant after applying a
Bonferroni correction; this may be due to the sample size. It has been suggested that dysfunction
of the fronto-subcortical system, which is involved in executive functioning, is implicated in the
causation of apathy [18], and that white matter damage to the cortico-subcortical pathways
Table 2. Binary logistic regression analysis.
Impaired Cognitive Index Impaired Memory/ Orientation Impaired Executive function/ processing speed
Presence of Apathy OR = 2.791 (1.323–6.325) OR = 1.505 (.588–3.853) OR = 2.371 (1.033–5.439)
p = .014 p = .394 p = .042
Presence of Depression OR = .905 (.301–2.717) OR = 1.631 (.489–5.446) OR = 1.249 (.415–3.762)
p = .858 p = .426 p = .692
Age OR = .988 (.9555–1.021) OR = .989 (.951–1.030) OR = .978 (.944–1.013)
p = .466 p = .602 p = .215
Gender OR = 1.034 (.504–2.123) OR = 1.412 (.616–3.233) OR = 1.166 (.553–2.459)
p = .927 p = .415 p = .686
Premorbid IQ OR = .933 (.901-.965) OR = .905 (.911-.981) OR = .934 (.903-.967)
p = .000 p = .000 p = .000
Values presented are Odd’s Ratios (95% confidence interval).
https://doi.org/10.1371/journal.pone.0176943.t002
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which connect brain regions important for regulating emotions, may cause an increase in the
prevalence of apathy and depression in SVD [34]. Most recently, apathy has been associated
with damage to white matter tracts connecting regions in the frontal lobe with both subcortical
structures and the temporal lobe [11], even when controlling for cognitive functioning. Some
regions associated with apathy overlap with those associated with cognitive functioning, espe-
cially processing speed [35]. This may imply that apathy and executive function share some
underlying mechanisms.
In the current study, the magnitude of apathetic symptoms was directly inversely associated
with memory/orientation, and indirectly via executive function/processing speed; in contrast
the presence of apathy (using a predefined cut-off score to define the condition), was not asso-
ciated with memory/orientation. This apparent discrepancy could be explained by the rela-
tively small percentage of patients with memory deficits, and by attention being needed to be
able to encode and process information in the working memory [36], but also because the neu-
rocognitive systems supporting memory might have less overlap than those that modulate
motivation. Previous studies have demonstrated that episodic memory is relatively spared in
early stages of SVD [3, 7, 20].
In this study we recruited unselected non-demented patients presenting with lacunar stroke
who had varying degrees of WMH from none to severe confluent changes. This represents a
broader spectrum than a previous study showing dissociation between apathy and depression
in SVD which only included patients with lacunar stroke and confluent WMH [11]. SVD rep-
resents a spectrum of disease from asymptomatic WMH in community populations, through
lacunar stroke to patients presenting with cognitive impairment and dementia [37]. Further
studies are required to determine whether these findings apply to the full spectrum of SVD
including patients with apparently “asymptomatic” WMH, enlarged perivascular space, cere-
bral microbleeds and brain atrophy.
We derived apathy and depression scores from the Geriatric Depression Scale. It has been
previously shown that it is possible to dissociate these two behavioral impairments using this
approach [11]. The cut-offs for defining the presence of apathy and depression were then
derived on the mean and standard deviation values in controls. Future studies in this area,
however, would benefit from a more extensive detailed assessment of apathy to replicate the
current results. For instance, by using the apathy evaluation scale [38] which divides apathy
into behavioral, cognitive and emotional symptoms, or the Lille Apathy Rating Scale [39],
dividing apathy into subdomains enabling the development of patient specific profiles. Fur-
thermore future studies should use a more comprehensive cognitive test battery to explore the
relationship between apathy and cognition in more detail.
Using clinical cut-offs for apathy and depression in this study resulted in a small number of
patients with apathy and especially depression, and therefore we could not compare patients
with depression only with the other patient groups. In contrast to this study, previous studies
have found that both presence of apathy and depression were increased in patients with SVD
[12, 40]. This could be due to the fact that previous studies have used scores such as the total
GDS score to define depression which include both apathetic and depressive symptoms. When
we split them as in this paper we find differential associations. Performing a path analysis
using continuous scores of the magnitude of apathetic and depressive symptoms demonstrates
an association between apathetic symptoms and cognition. Due to the cross-sectional nature
of this study, interpretation of the results in terms of causality must be done cautiously. Fol-
low-up studies should examine the course and interaction of apathy, depression and cognition
in SVD.
Apathy is defined as a diminished motivation, and lack of effort and executive control [13–
15], which could result in loss of interest and effort in cognitive testing. Hence, the relation
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between apathy and cognitive impairment could be due to an incapability of goal-oriented
thinking and behavior, instead of common underlying brain damage. However, in this study,
participants were sufficiently motivated to overcome apathetic symptoms to take part, and we
found an association only between apathy and impaired executive functioning/processing
speed. A lack of effort in our participants would have also led to a poor performance in mem-
ory/orientation where we found no significant relationship with the apathy score when we
used cut-off scores for cognitive impairment on each index score. Future studies should
include objective measures of effort, for example by adding tasks to investigate physical effort
[41].
In another study, apathetic patients were found to be older than non-apathetic patients
post-stroke [40]. In this SVD population, age was associated with the magnitude of depressive
symptoms, but not with the magnitude of apathetic symptoms. Given the small number of
patients with apathetic and depressive symptoms, we were not able to explore possible varia-
tion by age and gender in this study population. However, all analyses were corrected for age
and gender, and the associations between apathy and cognition remained significant after
these adjustments. Nevertheless, future studies should address possible differences by age and
gender in SVD.
This study has a number of clinical implications. Apathy may have a major impact on qual-
ity of life of both the patient and their partner/carer and may impact on rehabilitation after
stroke. The high prevalence of apathy in SVD, which is often undetected, emphasizes that it is
important to screen for apathetic symptoms in addition to screening for depressive symptoms
to guarantee an optimal treatment for the patient. However, how to treat apathy in SVD best
remains to be determined. More data is needed on the effectiveness of antidepressant and cog-
nitive behavioral therapy on improving apathetic, rather than depressive, symptoms in SVD.
In other neurological disorders such as Alzheimer’s or Parkinson’s disease, pharmacological
and cognitive behavioral psychotherapy approaches for apathy have been explored. Recently,
dopaminergic agonists have been suggested as treatment of apathy [18, 42]. Future studies
should explore the effectiveness of these treatment options in SVD.
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